Advances in Nanotechnology-Enabled Drug Delivery for Combining PARP Inhibitors and Immunotherapy in Advanced Ovarian Cancer. Biomol Biomed 2024, 24 (2), 230–237. https://doi.org/10.17305/bb.2023.9757.